10b5-1 Plans
Gary Gensler To Do More In First Months Than Jay Clayton Did In Four Years
The little regulator that could has 10b5-1 plans, SPACs, Twitter, accounting and chief compliance officers in his sights.
You’re Not Going To Believe This, But Vaccine Execs Sold A Lot More Stock Last Year Than The Year Before
Those 10b5-1 sales sure were preset perfectly for a pandemic.
Jay Clayton Doesn’t Want To Start Smacking Insider Skulls, So Don’t Make Him
He’s this close to not having to give a s**t about any of this any more, you guys. Come on.